Peer Recovery Support Services for Individuals in Recovery Residences on MOUD
NCT05616949 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2025-04-09
Summary
The United States is experiencing an unprecedented opioid epidemic with a rapid increase in overdose deaths. Medications for opioid use disorder (MOUD) including methadone, buprenorphine, and extended-release naltrexone are efficacious and the recommended standard of care, yet barriers to sustained MOUD treatment reduce the overall efficacy of MOUD. Rates of MOUD retention are alarmingly low and MOUD dropout predicts opioid use/relapse, overdose, and death. While previous research has identified predictors of MOUD retention and adherence, there are no evidence-based interventions to improve MOUD retention.
Recovery support services are a broad set of strategies to promote healthy outcomes among individuals with substance use disorder (SUD) that are typically separate from standard professional treatment. Among those strategies most utilized are peer recovery support services (PRSS) and recovery residences (RRs). PRSS include coaching, mentoring, education, and other supports delivered by individuals uniquely qualified by their lived experience with SUD. PRSS are increasingly utilized in a range of clinical settings, and advantages of PRSS include inherent shared understanding of addiction and a high degree of acceptance and understanding that is not found in most professional relationships. Existing research tentatively supports PRSS; however, the evidence to date is sparse and comes with significant methodological limitations and inconsistencies that make it difficult to conclude the efficacy of PRSS. No studies have examined the role of PRSS in promoting retention in MOUD. RRs provide a supportive living environment for persons in recovery from SUD and are widely utilized in the United States with an estimated 17,943 residences in 2020. Despite their proliferation, the evidence for RRs is only moderate and diminished by methodological weaknesses. Further, individuals on MOUD seeking housing through RRs often face increased MOUD-related stigma or may be disqualified from a RR for taking MOUD and need additional support to navigate these challenges.
The potential synergistic benefits of combining PRSS and RRs to improve MOUD retention are considerable. PRSS and RRs are already mainstays in the recovery support services repertoire and could be leveraged to support MOUD retention. For example, more frequent, informal outreach typical of PRSS could facilitate regular monitoring of shifting attitudes and behaviors related to MOUD. The structure and accountability embedded in RRs could be used to support MOUD adherence and retention. Waxing and waning motivation to participate in MOUD treatment is common, and standard treatment is often unsuccessful at identifying early signs of future dropout or facilitating re-engagement after dropout.
We will recruit participants on MOUD in RRs and provide them with PRSS using approaches such as recovery coaching and care navigation with a particular focus on supporting retention in MOUD care. PRSS will also provide assertive outreach between episodes of care, emphasize continuation in treatment and other recovery activities after leaving a RR (either successfully or unsuccessfully), and emphasize return to care after treatment dropout and/or relapse. The peers will be deeply embedded within the local provider community and care continuum to facilitate ease of care navigation. The ultimate goal of our research agenda is to test the efficacy of a PRSS intervention among individuals with OUD living in RRs through a rigorous trial. The eventual trial design would be informed by preparatory activities and experience proposed in this planning project.
Preparatory activities proposed in this project include three major phases. Phase 1 - preparation for the intervention including: building a network of RRs that will be recruitment sites in the pilot RCT, recruiting and training peer support specialists, conducting focus groups and interviews to gather stakeholder input, and developing PRSS approaches to promote MOUD retention. Phase 2 - pilot test the PRSS intervention by randomizing N=50 individuals on MOUD recruited from collaborating RRs to either: a 24-week course of the PRSS intervention added to usual services, or usual services without the PRSS intervention. Phase 3 - gather additional input from former participants and RR staff post-intervention to further refine the intervention, and use lessons learned to inform our trial design and data collection procedures for the next-step R01 application.
Conditions
- Opioid Use Disorder
- Substance Use Disorder
Interventions
- BEHAVIORAL
-
Treatment as Usual (TAU) (Arm 1)
Treatment as Usual (TAU): The treatment and/or other services received as part of usual care while living in a recovery residence. This arm serves as the active comparator group for the study.
- BEHAVIORAL
-
Peer Recovery Support Services (PRSS) + TAU (experimental- Arm 2)
Peer Recovery Support Services (PRSS) Intervention: The experimental group for this study that involves the implementation of the PRSS intervention. This study will test the preliminary efficacy of the PRSS intervention on Medications for Opioid Use Disorder (MOUD) retention by evenly randomizing N=50 individuals on MOUD living in recovery residences (RRs) to either a 24-week course of the experimental PRSS intervention layered on top of treatment as usual services
Sponsors & Collaborators
-
National Institute of Drug Abuse
collaborator FED -
National Institutes of Health (NIH)
collaborator NIH -
Potomac Health Foundations
lead OTHER
Principal Investigators
-
Kevin R. Wenzel, Ph.D. · Mountain Manor Treatment Center - Maryland Treatment Centers
-
Marc J. Fishman, M.D. · Mountain Manor Treatment Center - Maryland Treatment Centers
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-07-14
- Primary Completion
- 2025-04-01
- Completion
- 2025-09-29
Countries
- United States
Study Locations
More Related Trials
-
Enhancing Recovery Capital Amid Opioid Use Disorder Pharmacotherapy: A Pilot Randomized Trial
NCT05245513 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
FOREward Together: Training Peer Recovery Coaches to Promote Retention and Adherence to MOUD
NCT05098795 ·Status: COMPLETED ·Phase: NA
-
Peer-Delivered Behavioral Activation for Methadone Adherence - Pilot Phase
NCT04248933 ·Status: COMPLETED ·Phase: NA
-
Integrating MOUD in Nonmedical Community Settings (Better Together)
NCT06416020 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Evaluation of a Peer Recovery Support Program Adapted to Target Retention in Clinic-based Medication for Opioid Use Disorder Treatment
NCT07197801 ·Status: RECRUITING ·Phase: NA
-
Transforming Recovery Through Exercise and Community
NCT03065049 ·Status: COMPLETED ·Phase: NA
-
Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement
NCT06033599 ·Status: RECRUITING ·Phase: PHASE3
-
Behavioral Pharmacological Examination of a Novel Buprenorphine Induction Method Among Individuals Who Use Fentanyl
NCT06089707 ·Status: RECRUITING ·Phase: PHASE3
-
Therapy and Peer Support for Patients Taking Medication for Opioid Use Disorder
NCT04257214 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Tailored, Peer-delivered Intervention to Reduce Recurring Opioid Overdoses
NCT02922959 ·Status: COMPLETED ·Phase: NA
-
Preventing Parental Opioid and/or Methamphetamine Addiction Within DHS-Involved Families: PRE-FAIR
NCT05380440 ·Status: COMPLETED ·Phase: NA
-
The MOUD Plus Pilot: Counseling and Peer Support to Support Retention for Medically Complex Patients With Opioid Use Disorder Seen In Primary Care
NCT06837662 ·Status: RECRUITING ·Phase: NA
-
Therapy and Peer Support for Patients Taking Medication for Opioid Use Disorder
NCT06359340 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Activating Community Support for Substance Users
NCT03194295 ·Status: COMPLETED ·Phase: PHASE2
-
MHealth Incentivized Adherence Plus Patient Navigation
NCT06027814 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Improving Treatment and Recovery Services for Individuals With Opioid Problems
NCT05129813 ·Status: UNKNOWN
-
Peer Supported Collaborative Care Mental Health and Substance Use Disorder Care
NCT04601064 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Treatment of Opioid Use: Medication Adherence Therapy
NCT03567356 ·Status: COMPLETED ·Phase: NA
-
A Comprehensive Peer Mentor-based Disease Management Program for Medically Complex Substance Users
NCT00993395 ·Status: WITHDRAWN ·Phase: NA
-
Peer Activate: Trial of Peer-Delivered Behavioral Activation for Methadone Adherence
NCT05299515 ·Status: COMPLETED ·Phase: NA
-
Pharmacist-Led Interventions to Increase Access to Medications for Opioid Use Disorders (PLI-MOUD)
NCT05776823 ·Status: COMPLETED ·Phase: NA
-
Impact of Federal and State Medications for Opioid Use Disorder (MOUD) Policy Changes During the Pandemic
NCT07232641 ·Status: NOT_YET_RECRUITING
-
Developing SUPPORT, a Community-Driven, Recovery-Oriented System of Care
NCT03132753 ·Status: COMPLETED ·Phase: NA
-
Integrated Collaborative Care for Substance Use Disorders
NCT01810159 ·Status: COMPLETED ·Phase: NA
-
Initiating Substance Use Disorder Treatment for Hospitalized Opioid Use Disorder Patients.
NCT03212794 ·Status: COMPLETED ·Phase: NA